In this report, the global Metabolism Drugs market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Global Metabolism Drugs Market – Insights
Metabolism drugs are used for the treatment of metabolic syndrome and metabolic disorders such as acid-base imbalance, metabolic brain diseases, disorders of calcium metabolism, DNA repair-deficiency disorders, and glucose metabolism disorders. Changing lifestyle and high consumption of junk food may contribute to the increasing demand for metabolism drugs.
Increasing prevalence of diabetes is expected to boost growth of the global metabolism drugs market over the forecast period. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018. Moreover, increasing incidence of obesity is also expected to fuel growth of the market. For instance, according to MedAlertHelp.org, over 1.9 billion adults were reported as overweight worldwide.
The risk of metabolic syndrome increases with age. Therefore, increasing geriatric population is expected to offer lucrative growth opportunities for players in the global metabolism drugs market. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015. Moreover, increasing R&D in brain network dynamics for treatment and management of glucose metabolism disorders is also expected to aid in growth of the market. For instance, researchers from University of North Carolina collaborated with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to delineate how brain network dynamics are modulated by experimentally induced elevated blood glucose levels and examine how glucose levels gate neuronal excitability measured by the response to Transcranial magnetic stimulation. The study is expected to be complete in December 2019.
However, metabolism drugs may lead to side effects such as nausea, constipation or diarrhea, which are expected to hinder growth of the global metabolism drugs market. Moreover, some weight-loss drugs can be expensive and are not always paid for by insurance, which is also expected to hamper the market growth.
Key players in the market are focused on patenting their novel products to enhance their market share. For instance, in December 2019, BioRestorative Therapies, Inc. received a Notice of Allowance on its patent application for a method of generating brown fat stem cells from Israeli Patent Office.
Key Takeaways:
• Increasing prevalence of diabetes is expected to augment growth of the global metabolism drugs market over the forecast period
• Side effects related to metabolism drugs may hamper growth of the market
• Major players operating in the global metabolism drugs market include BioRestorative Therapies, Inc., Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, and Metsubishi Tanabe Pharma
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Metabolism Drugs for these regions, from 2014 to 2025 (forecast), covering
• United States
• China
• Europe
• Japan
• Southeast Asia
• India
Global Metabolism Drugs market competition by top manufacturers/players, with Metabolism Drugs sales volume, Price (USD/Unit), Revenue (Million USD) and market share for each manufacturer/player; the top players including
• Merck
• Novartis
• Takeda Pharmaceutical
• Astra Zeneca
• Beohrigher Ingelheim
• KOWA
• Kythera
• Fuji yakuhin
• LG Life Science
• Metsubishi Tanabe Pharma
On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into
• Glycogen Metabolism Disease Drug
• Lipid Metabolism Disease Drug
• Amino Acid Metabolism Drug
• Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Metabolism Drugs for each application, including
• Hospital
• Retail Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Metabolism Drugs Sales Market Report 2019
1 Metabolism Drugs Market Overview
1.1 Product Overview and Scope of Metabolism Drugs
1.2 Classification of Metabolism Drugs by Product Category
1.2.1 Global Metabolism Drugs Market Size (Sales) Comparison by Type (2014-2025)
1.2.2 Global Metabolism Drugs Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Glycogen Metabolism Disease Drug
1.2.4 Lipid Metabolism Disease Drug
1.2.5 Amino Acid Metabolism Drug
1.2.6 Other
1.3 Global Metabolism Drugs Market by Application/End Users
1.3.1 Global Metabolism Drugs Sales (Volume) and Market Share Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Metabolism Drugs Market by Region
1.4.1 Global Metabolism Drugs Market Size (Value) Comparison by Region (2014-2025)
1.4.2 United States Metabolism Drugs Status and Prospect (2014-2025)
1.4.3 China Metabolism Drugs Status and Prospect (2014-2025)
1.4.4 Europe Metabolism Drugs Status and Prospect (2014-2025)
1.4.5 Japan Metabolism Drugs Status and Prospect (2014-2025)
1.4.6 Southeast Asia Metabolism Drugs Status and Prospect (2014-2025)
1.4.7 India Metabolism Drugs Status and Prospect (2014-2025)
1.5 Global Market Size (Value and Volume) of Metabolism Drugs (2014-2025)
1.5.1 Global Metabolism Drugs Sales and Growth Rate (2014-2025)
1.5.2 Global Metabolism Drugs Revenue and Growth Rate (2014-2025)
2 Global Metabolism Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Metabolism Drugs Market Competition by Players/Suppliers
2.1.1 Global Metabolism Drugs Sales and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Global Metabolism Drugs Revenue and Share by Players/Suppliers (2014-2019)
2.2 Global Metabolism Drugs (Volume and Value) by Type
2.2.1 Global Metabolism Drugs Sales and Market Share by Type (2014-2019)
2.2.2 Global Metabolism Drugs Revenue and Market Share by Type (2014-2019)
2.3 Global Metabolism Drugs (Volume and Value) by Region
2.3.1 Global Metabolism Drugs Sales and Market Share by Region (2014-2019)
2.3.2 Global Metabolism Drugs Revenue and Market Share by Region (2014-2019)
2.4 Global Metabolism Drugs (Volume) by Application
3 United States Metabolism Drugs (Volume, Value and Sales Price)
3.1 United States Metabolism Drugs Sales and Value (2014-2019)
3.1.1 United States Metabolism Drugs Sales and Growth Rate (2014-2019)
3.1.2 United States Metabolism Drugs Revenue and Growth Rate (2014-2019)
3.1.3 United States Metabolism Drugs Sales Price Trend (2014-2019)
3.2 United States Metabolism Drugs Sales Volume and Market Share by Players
3.3 United States Metabolism Drugs Sales Volume and Market Share by Type
3.4 United States Metabolism Drugs Sales Volume and Market Share by Application
4 China Metabolism Drugs (Volume, Value and Sales Price)
4.1 China Metabolism Drugs Sales and Value (2014-2019)
4.1.1 China Metabolism Drugs Sales and Growth Rate (2014-2019)
4.1.2 China Metabolism Drugs Revenue and Growth Rate (2014-2019)
4.1.3 China Metabolism Drugs Sales Price Trend (2014-2019)
4.2 China Metabolism Drugs Sales Volume and Market Share by Players
4.3 China Metabolism Drugs Sales Volume and Market Share by Type
4.4 China Metabolism Drugs Sales Volume and Market Share by Application
5 Europe Metabolism Drugs (Volume, Value and Sales Price)
5.1 Europe Metabolism Drugs Sales and Value (2014-2019)
5.1.1 Europe Metabolism Drugs Sales and Growth Rate (2014-2019)
5.1.2 Europe Metabolism Drugs Revenue and Growth Rate (2014-2019)
5.1.3 Europe Metabolism Drugs Sales Price Trend (2014-2019)
5.2 Europe Metabolism Drugs Sales Volume and Market Share by Players
5.3 Europe Metabolism Drugs Sales Volume and Market Share by Type
5.4 Europe Metabolism Drugs Sales Volume and Market Share by Application
6 Japan Metabolism Drugs (Volume, Value and Sales Price)
6.1 Japan Metabolism Drugs Sales and Value (2014-2019)
6.1.1 Japan Metabolism Drugs Sales and Growth Rate (2014-2019)
6.1.2 Japan Metabolism Drugs Revenue and Growth Rate (2014-2019)
6.1.3 Japan Metabolism Drugs Sales Price Trend (2014-2019)
6.2 Japan Metabolism Drugs Sales Volume and Market Share by Players
6.3 Japan Metabolism Drugs Sales Volume and Market Share by Type
6.4 Japan Metabolism Drugs Sales Volume and Market Share by Application
7 Southeast Asia Metabolism Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Metabolism Drugs Sales and Value (2014-2019)
7.1.1 Southeast Asia Metabolism Drugs Sales and Growth Rate (2014-2019)
7.1.2 Southeast Asia Metabolism Drugs Revenue and Growth Rate (2014-2019)
7.1.3 Southeast Asia Metabolism Drugs Sales Price Trend (2014-2019)
7.2 Southeast Asia Metabolism Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Metabolism Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Metabolism Drugs Sales Volume and Market Share by Application
8 India Metabolism Drugs (Volume, Value and Sales Price)
8.1 India Metabolism Drugs Sales and Value (2014-2019)
8.1.1 India Metabolism Drugs Sales and Growth Rate (2014-2019)
8.1.2 India Metabolism Drugs Revenue and Growth Rate (2014-2019)
8.1.3 India Metabolism Drugs Sales Price Trend (2014-2019)
8.2 India Metabolism Drugs Sales Volume and Market Share by Players
8.3 India Metabolism Drugs Sales Volume and Market Share by Type
8.4 India Metabolism Drugs Sales Volume and Market Share by Application
9 Global Metabolism Drugs Players/Suppliers Profiles and Sales Data
9.1 Merck
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Metabolism Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Merck Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business/Business Overview
9.2 Novartis
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Metabolism Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business/Business Overview
9.3 Takeda Pharmaceutical
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Metabolism Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Pharmaceutical Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business/Business Overview
9.4 Astra Zeneca
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Metabolism Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Astra Zeneca Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business/Business Overview
9.5 Beohrigher Ingelheim
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Metabolism Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Beohrigher Ingelheim Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business/Business Overview
9.6 KOWA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Metabolism Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 KOWA Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business/Business Overview
9.7 Kythera
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Metabolism Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Kythera Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business/Business Overview
9.8 Fuji yakuhin
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Metabolism Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business/Business Overview
9.9 LG Life Science
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Metabolism Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business/Business Overview
9.10 Metsubishi Tanabe Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Metabolism Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.10.4 Main Business/Business Overview
10 Metabolism Drugs Maufacturing Cost Analysis
10.1 Metabolism Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Metabolism Drugs
10.3 Manufacturing Process Analysis of Metabolism Drugs
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Metabolism Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2018
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Metabolism Drugs Market Forecast (2019-2025)
14.1 Global Metabolism Drugs Sales Volume, Revenue and Price Forecast (2019-2025)
14.1.1 Global Metabolism Drugs Sales Volume and Growth Rate Forecast (2019-2025)
14.1.2 Global Metabolism Drugs Revenue and Growth Rate Forecast (2019-2025)
14.1.3 Global Metabolism Drugs Price and Trend Forecast (2019-2025)
14.2 Global Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
14.2.1 Global Metabolism Drugs Sales Volume and Growth Rate Forecast by Regions (2019-2025)
14.2.2 Global Metabolism Drugs Revenue and Growth Rate Forecast by Regions (2019-2025)
14.2.3 United States Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
14.2.4 China Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
14.2.5 Europe Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
14.2.6 Japan Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
14.2.7 Southeast Asia Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
14.2.8 India Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast (2019-2025)
14.3 Global Metabolism Drugs Sales Volume, Revenue and Price Forecast by Type (2019-2025)
14.3.1 Global Metabolism Drugs Sales Forecast by Type (2019-2025)
14.3.2 Global Metabolism Drugs Revenue Forecast by Type (2019-2025)
14.3.3 Global Metabolism Drugs Price Forecast by Type (2019-2025)
14.4 Global Metabolism Drugs Sales Volume Forecast by Application (2019-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Request Discount 
Inquire Before Buy
